The body's defense against infection is provided by the intricate network of organs, cells,
and proteins known as the immune system. The two types of adaptive immune responses …

Monoclonal antibodies have not been a major contributor to the category of anti-infective
agents, partly due to the presence of effective vaccines and antibodies. However, some …

Immune-based therapies are being studied extensively in a variety of immunological
conditions due to their high precision and sensitivity. Monoclonal antibody (mAb) technology …

Highlights•More than 100 new experimental antibodies now enter into development each
year.•Half of experimental monoclonal antibodies and a third of approvals are potential …

Introduction. Recently, monoclonal antibodies (mAbs) have become powerful human
therapeutics in the diagnosis and treatment of many diseases. Drugs based on mAbs are …

Highlights•Heterogeneity and plasticity are key obstacles in cancer and infectious
diseases.•Oligoclonal antibodies are uniquely suited to address and overcome these …

Monoclonal antibodies (mAbs) are being used to prevent, detect, and treat a broad spectrum
of malignancies and infectious and autoimmune diseases. Over the past few years, the …

Modern-day medicine has been revolutionized to be personalized and specific based on
individualized specific disease characteristics. Monoclonal antibodies (mAbs) are a prime …

With the flourishing of innovation in drug discovery into a new era of personalized therapy,
the use of monoclonal antibodies (mAbs) in the treatment of various ailments lies at the …

Antibody engineering has developed into a wide-reaching field, impacting a multitude of
industries, most notably healthcare and diagnostics. The seminal work on developing the …